LBT-3627

LBT-3627 · Longevity Biotech Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LBT-3627, covering 2025-05-13 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease. [Phase 1]

See pricing